M. H. Le

C-myc PROTO-ONCOGENE EXPRESSION AND PROGNOSIS IN EARLY CARCINOMA OF THE UTERINE CERVIX

G Riou, M. H. Le, V Le Doussal et al. · The Lancet · 1987 · 148 citations

Tumor Biology, Cervical Cancer, Oncogenic Agent +8

Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status

Rafaela L. Rego, Nathan R. Foster, Thomas C. Smyrk et al. · British Journal of Cancer · 2009 · 94 citations · Full text

Lymphoma Presenting as a Soft Tissue Mass

Timothy A. Damron, M. H. Le, Michele T. Rooney et al. · Clinical Orthopaedics and Related Research · 1999 · 32 citations

Results of an ongoing open-label, phase II study of carfilzomib in patients with relapsed and/or refractory multiple myeloma (R/R MM).

Ravi Vij, David S. Siegel, J. L. Kaufman et al. · Journal of Clinical Oncology · 2010 · 21 citations

Quantitative Pharmacology, Pathology, Phase Ii Study +22

The effects of interaction between familial and reproductive factors on breast cancer risk: a combined analysis of seven case-control studies

Nadine Andrieu, Teresa Smith, Stephen W. Duffy et al. · British Journal of Cancer · 1998 · 17 citations · Full text

Family Medicine, Breast Oncology, Breast Cancer Risk +14